MiMedx Group (MDXG) Competitors $6.88 -0.04 (-0.58%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MDXG vs. SLNO, IRTC, TMDX, PRCT, NVST, LMAT, NVCR, LIVN, ENOV, and WRBYShould you be buying MiMedx Group stock or one of its competitors? The main competitors of MiMedx Group include Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), LeMaitre Vascular (LMAT), NovoCure (NVCR), LivaNova (LIVN), Enovis (ENOV), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. MiMedx Group vs. Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista LeMaitre Vascular NovoCure LivaNova Enovis Warby Parker MiMedx Group (NASDAQ:MDXG) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment, risk and community ranking. Is MDXG or SLNO more profitable? MiMedx Group has a net margin of 23.86% compared to Soleno Therapeutics' net margin of 0.00%. MiMedx Group's return on equity of 26.21% beat Soleno Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets MiMedx Group23.86% 26.21% 18.15% Soleno Therapeutics N/A -61.99%-55.21% Does the media favor MDXG or SLNO? In the previous week, Soleno Therapeutics had 1 more articles in the media than MiMedx Group. MarketBeat recorded 13 mentions for Soleno Therapeutics and 12 mentions for MiMedx Group. MiMedx Group's average media sentiment score of 1.25 beat Soleno Therapeutics' score of 1.23 indicating that MiMedx Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiMedx Group 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Soleno Therapeutics 7 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor MDXG or SLNO? Soleno Therapeutics received 273 more outperform votes than MiMedx Group when rated by MarketBeat users. However, 82.76% of users gave MiMedx Group an outperform vote while only 72.62% of users gave Soleno Therapeutics an outperform vote. CompanyUnderperformOutperformMiMedx GroupOutperform Votes4882.76% Underperform Votes1017.24%Soleno TherapeuticsOutperform Votes32172.62% Underperform Votes12127.38% Do analysts rate MDXG or SLNO? MiMedx Group presently has a consensus price target of $12.50, suggesting a potential upside of 81.69%. Soleno Therapeutics has a consensus price target of $104.67, suggesting a potential upside of 39.82%. Given MiMedx Group's higher possible upside, equities research analysts plainly believe MiMedx Group is more favorable than Soleno Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.20 Which has more volatility & risk, MDXG or SLNO? MiMedx Group has a beta of 1.74, indicating that its stock price is 74% more volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.29, indicating that its stock price is 329% less volatile than the S&P 500. Which has stronger valuation and earnings, MDXG or SLNO? MiMedx Group has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMiMedx Group$348.88M2.91$58.23M$0.2824.57Soleno TherapeuticsN/AN/A-$38.99M-$4.26-17.57 Do institutionals & insiders believe in MDXG or SLNO? 79.2% of MiMedx Group shares are held by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are held by institutional investors. 1.3% of MiMedx Group shares are held by insiders. Comparatively, 12.3% of Soleno Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryMiMedx Group beats Soleno Therapeutics on 11 of the 18 factors compared between the two stocks. Get MiMedx Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDXG vs. The Competition Export to ExcelMetricMiMedx GroupSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.01B$4.39B$5.56B$7.83BDividend YieldN/A39.94%5.11%4.22%P/E Ratio12.5130.6722.4418.48Price / Sales2.9154.91393.95103.59Price / Cash41.7551.0838.1834.62Price / Book7.026.116.774.25Net Income$58.23M$68.15M$3.22B$248.23M7 Day Performance1.18%-0.12%1.45%0.89%1 Month Performance-8.27%-2.24%3.96%3.53%1 Year Performance-5.88%24.15%16.07%5.08% MiMedx Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDXGMiMedx Group3.3954 of 5 stars$6.88-0.6%$12.50+81.7%+11.7%$1.01B$348.88M12.51870Earnings ReportNews CoveragePositive NewsSLNOSoleno Therapeutics4.6454 of 5 stars$73.64+0.5%$104.67+42.1%+67.6%$3.68BN/A-22.1830Upcoming EarningsPositive NewsIRTCiRhythm Technologies0.9812 of 5 stars$106.64+0.6%$119.73+12.3%-2.5%$3.40B$591.84M-29.301,790News CoveragePositive NewsTMDXTransMedics Group3.1986 of 5 stars$90.19-3.5%$122.70+36.0%-2.3%$3.05B$441.54M95.95210Upcoming EarningsAnalyst ForecastGap DownPRCTPROCEPT BioRobotics2.7276 of 5 stars$54.16+3.2%$90.00+66.2%+1.9%$2.97B$249.12M-27.77430Earnings ReportAnalyst RevisionPositive NewsNVSTEnvista4.4363 of 5 stars$15.97+0.2%$19.96+25.0%-18.3%$2.75B$2.51B-2.4612,700Analyst ForecastLMATLeMaitre Vascular2.1696 of 5 stars$91.54-0.1%$98.14+7.2%+40.0%$2.07B$219.86M50.02490News CoverageNVCRNovoCure3.7436 of 5 stars$18.31-1.0%$32.83+79.3%+48.2%$2.04B$605.22M-13.081,320Earnings ReportLIVNLivaNova3.8194 of 5 stars$37.51+0.7%$61.17+63.1%-33.6%$2.04B$1.25B89.312,900Upcoming EarningsNews CoveragePositive NewsENOVEnovis2.7329 of 5 stars$34.67-1.2%$58.50+68.7%-37.4%$1.98B$2.11B-15.836,800Upcoming EarningsPositive NewsWRBYWarby Parker3.8606 of 5 stars$15.47-0.3%$22.93+48.2%+40.7%$1.60B$771.32M-57.303,030Upcoming EarningsAnalyst Upgrade Related Companies and Tools Related Companies Soleno Therapeutics Alternatives iRhythm Technologies Alternatives TransMedics Group Alternatives PROCEPT BioRobotics Alternatives Envista Alternatives LeMaitre Vascular Alternatives NovoCure Alternatives LivaNova Alternatives Enovis Alternatives Warby Parker Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDXG) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiMedx Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDXG Stock Free MDXG Stock Alerts